Argenx
ARGX
#425
Rank
$54.67 B
Marketcap
$877.94
Share price
-1.30%
Change (1 day)
44.59%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report